Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer

Human Gene Therapy

Volumn 10, Issue 18, 1999, Pages 2987-2997

  Bemelmans, Alexis Pierre ^a   Horellou, Philippe ^a   Pradier, Laurent ^b   Brunet, Isabelle ^a   Colin, Philippe ^a   Mallet, Jacques ^a,c  

^a Lab Genet Molec N   (France)

^b SANOFI   (France)

^c Hop de la Pitie Salpetriere   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CORPUS STRIATUM; GENE TRANSFER; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; RAT;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUNTINGTON DISEASE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

ADENOVIRIDAE; ANIMALIA;

EID: 0033544840     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016393     Document Type: Article

References (50)

1. 125I]NT-3. Eur. J. Neurosci. 6, 1389-1405.
2. ALTAR, C.A., CAI, N., BLIVEN, T., JUHASZ, M., CONNER, J.M., ACHESON, A.L., LINDSAY, R.M., and WIEGAND, S.J. (1997). Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature (London) 389, 856-860.
3. ANDERSON, K.D., PANAYOTATOS, N., CORCORAN, T.L., LINDSAY, R.M., and WIEGAND, S.J. (1996). Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 93, 7346-7351.
4. ARAUJO, D.M., and HILT, D.C. (1997). Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease. Neuroscience 81, 1099-1110.
5. BARKATS, M., BEMELMANS, A.-P., GEOFFROY, M.-C., ROBERT, J.-J., LOQUET, I., HORELLOU, P., REVAH, F., and MALLET, J. (1996). An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. NeuroReport 7, 497-501.
6. BAUMGARTNER, B.J., and SHINE, H.D. (1997). Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J. Neurosci. 17, 6504-6511.
7. BEAL, M.F., KOWALL, N.W., ELLISON, D.W., MAZUREK, M.F., SWARTZ, K.J., and MARTIN, J.B. (1986). Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (London) 321, 168-171.
8. BHAVE, S.V., GHODA, L., and HOFFMAN, P.L. (1999). Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: Signal transduction cascades and site of ethanol action. J. Neurosci. 19, 3277-3286.
9. BILANG-BLEUEL, A., REVAH, F., COLIN, P., LOCQUET, I., ROBERT, J.J., MALLET, J., and HORELLOU, P. (1997). Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 94, 8818-8823.
10. BLÖMER, U., NALDINI, L., KAFRI, T., TRONO, D., VERMA, I.M., and GAGE, F.H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
11. BRIZZARD, B.L., CHUBET, R.G., and VIZARD, D.L. (1994). Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. BioTechniques 16, 730-735.
12. BYRNES, A.P., RUSBY, J.E., WOOD, M.J.A., and CHARLTON, H.M. (1995). Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66, 1015-1024.
13. BYRNES, A.P., MACLAREN, R.E., and CHARLTON, H.M. (1996). Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16, 3045-3055.
14. CASTEL-BARTHE, M.N., JAZAT-POINDESSOUS, F., BARNEOUD, P., VIGNE, E., REVAH, F., MALLET, J., and LAMOUR, Y. (1996). Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging. Neurobiol. Dis. 3, 76-86.
15. CHOI, D.W. (1994). Calcium and excitotoxic neuronal injury. Ann. N.Y. Acad. Sci. 747, 162-171.
16. CONNER, J.M., LAUTERBORN, J.C., YAN, Q., GALL, C.M., and VARON, S. (1997). Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17, 2295-2313.
17. DAVIES, S.W., TURMAINE, M., COZENS, B.A., DIFIGLIA, M., SHARP, A.H., ROSS, C.A., SCHERZINGER, E., WANKER, E.E., MANGIARINI, L., and BATES, G.P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
18. DEDIEU, J.-F., VIGNE, E., TORRENT, C., JULLIEN, C., MAHFOUZ, I., CAILLAUD, J.M., AUBAILLY, N., ORSINI, C., GUILLAUME, J.M., OPOLON, P., DELAERE, P., PERRICAUDET, M., and YEH, P. (1997). Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71, 4626-4637.
19. DIFIGLIA, M. (1990). Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trends Neurosci. 13, 286-289.
20. DIFIGLIA, M., SAPP, E., CHASE, K.O., DAVIES, S.W., BATES, G.P., VONSATTEL, J.P., and ARONIN, N. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
21. EMERICH, D.F., WINN, S.R., HANTRAYE, P.M., PESCHANSKI, M., CHEN, E.Y., CHU, Y., McDERMOTT, P., BAETGE, E.E., and KORDOWER, J.H. (1997). Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature (London) 386, 395-399.
22. FRIM, D.M., UHLER, T.A., SHORT, M.P., EZZEDINE, Z.D., KLAGSBRUN, M., BREAKEFIELD, X.O. and ISACSON, O. (1993). Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. NeuroReport 4, 367-370.
23. GIMENEZ Y RIBOTTA, M., REVAH, F., PRADIER, L., LOQUET, I., MALLET, J., and PRIVAT, A. (1997). Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J. Neurosci. Res. 48, 281-285.
24. HIRSCH, E., LEJEUNE, O., COLLIOT, G., CORKIDI, G., and TAJANI, M. (1992). Computer methods in nuclei cartography. In Methods in Neurosciences. P. Coon, ed. (Academic Press, San Diego, CA) pp. 62-79.
25. HORELLOU, P., and MALLET, J. (1998). Neuronal grafts for Huntington's disease. Nature Med. 4, 669-670.
26. HUNTINGTON'S DISEASE RESEARCH COLLABORATIVE GROUP. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
27. IVKOVIC, S., POLONSKAIA, O., FARINAS, I., and EHRLICH, M.E. (1997). Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: Studies in vivo and in vitro. Neurosciences 79, 509-516.
28. JONES, K.R., FARINAS, I., BACKUS, C. and REICHARDT, L.F. (1994). Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999.
29. KAAL, E.C., JOOSTEN, E.A., and BAR, P.R. (1997). Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract. Neurochem. Int. 31, 193-201.
30. KOPYOV, O.V., JACQUES, S., LIEBERMAN, A., DUMA, C.M., and EAGLE, K.S. (1998). Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149, 97-108.
31. LE GAL LA SALLE, G., ROBERT, J.-J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
32. MARTINEZ-SERRANO, A., and BJORKLUND, A. (1996). Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 16, 4604-4616.
33. MATTSON, M.P., RYCHLIK, B., CHU, C., and CHRISTAKOS, S. (1991). Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6, 41-51.
34. MIZUNO, K., CARNAHAN, J., and NAWA, H. (1994). Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 165, 243-256.
35. NAKAO, N., BRUNDIN, P., FUNA, K., LINDVALL, O., and ODIN, P. (1995). Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res. Dev. Brain Res. 90, 92-101.
36. ONA, V.O., LI, M., VONSATTEL, J.P., ANDREWS, L.J., KHAN, S.Q., CHUNG, W.M., FREY, A.S., MENON, A.S., LI, X.J., STIEG, P.E., YUAN, J., PENNEY, J.B., YOUNG, A.B., CHAN, J.H., and FRIEDLANDER, R.M. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (London) 399, 263-267.
37. ORDWAY, J.M., TALLAKSEN, G.S., GUTEKUNST, C.A., BERNSTEIN, E.M., CEARLEY, J.A., WIENER, H.W., DURE, L.T., LINDSEY, R., HERSCH, S.M., JOPE, R.S., ALBIN, R.L., and DETLOFF, P.J. (1997). Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-763.
38. OUIMET, C.C., MILLER, P.E., HEMMINGS, H.C., JR., WALAAS, S.I., and GREENGARD, P. (1984). DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111-124.
39. PORTERA-CAILLIAU, C., HEDREEN, J.C., PRICE, D.L., and KOLIATSOS, V.E. (1995). Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
40. PRICE, D.L., SISODIA, S.S., and BORCHELT, D.R. (1998). Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 1079-1083.
41. SANCHEZ, I., XU, C.J., JUO, P., KAKIZAKA, A., BLENIS, J., and YUAN, J. (1999). Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
42. SAUDOU, F., FINKBEINER, S., DEVYS, D., and GREENBERG, M.E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
43. SHARP, A.H., LOEV, S.J., SCHILLING, G., LI, S.H., LI, X.J., BAO, J., WAGSTER, M.V., KOTZUK, J.A., STEINER, J.P., LO, A., HEDDREEN, J., SISODIA, S., SNYDER, S.H., DAWSON, T.M., RYUGO, D.K., and ROSS, C.A. (1995). Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074.
44. SISODIA, S.S. (1998). Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial? Cell 95, 1-4.
45. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
46. TROTTIER, Y., DEVYS, D., IMBERT, G., SAUDOU, F., AN, I., LUTZ, Y., WEBER, C., AGID, Y., HIRSCH, E.C., and MANDEL, J.L. (1995). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104-110.
47. VENTIMIGLIA, R., MATHER, P.E., JONES, B.E., and LINDSAY, R.M. (1995). The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7, 213-222.
48. WEISS, S., PIN, J.P., SEBBEN, M., KEMP, D.E., SLADECZEK, F., GABRION, J., and BOCKAERT, J. (1986). Synaptogenesis of cultured striatal neurons in serum-free medium: A morphological and biochemical study. Proc. Natl. Acad. Sci. U.S.A. 83, 2238-2242.
49. WIDMER, H.R., and HEFTI, F. (1994). Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture. Eur. J. Neurosci. 6, 1669-1679.
50. WU, K., XU, J.L., SUEN, P.C., LEVINE, E., HUANG, Y.Y., MOUNT, H.T., LIN, S.Y., and BLACK, I.B. (1996). Functional trkB neurotrophin receptors are intrinsic components of the adult brain post-synaptic density. Brain. Res. Mol. Brain Res. 43, 286-290.